SCHEMBL8081802

SCHEMBL8081802

CC/C=C/c1nc(Cl)c(C=O)n1Cc1ccc(-c2ccccc2C(=O)OCc2ncc[nH]2)cc1

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GP6 Q9HCN6 1/20 0.38
AGTR2 P50052 2/20 0.35
AGTR1 P30556 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL419 0.84 SLC6A4 (0.46) GP6AGTR2AGTR1
SCHEMBL417 0.84 SLC6A4 (0.46) GP6AGTR2AGTR1
SCHEMBL138 0.81 AGTR1 (0.52) AGTR2AGTR1
SCHEMBL136 0.81 AGTR1 (0.52) AGTR2AGTR1
SCHEMBL10587702 0.74 AGTR1 (0.45) AGTR2AGTR1
SCHEMBL10587697 0.74 AGTR1 (0.45) AGTR2AGTR1
SCHEMBL410 0.73 AGTR2 (0.52) AGTR2AGTR1
SCHEMBL408 0.73 AGTR2 (0.52) AGTR2AGTR1
SCHEMBL8080984 0.72 AGTR1 (0.39) AGTR2AGTR1
SCHEMBL11 0.71 GP6 (0.49) GP6AGTR2AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2000508347-A 2000-07-04 JP claimed
EP-0966282-A1 USE OF ANGIOTENSIN II ANTAGONISTS TO TREAT SYMPTOMATIC HEART FAILURE Merck & Co., Inc. (US) 1999-12-29 EP claimed
WO-1998030216-A1 USE OF ANGIOTENSIN II ANTAGONISTS TO TREAT SYMPTOMATIC HEART FAILURE MERCK & CO., INC. (US) 1998-07-16 WO claimed